# Garzulys

NDC: 71288-903
Generic name: insulin aspart-fsan
Labeler / Manufacturer: Meitheal Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20260724

FDA application: BLA761497

## Active ingredients

- INSULIN ASPART: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71288-903"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71288-903
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30c64769-d2f7-4604-ac9e-2a6bc09506c9